{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:25:31Z","timestamp":1790281531898,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T00:00:00Z","timestamp":1530316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Kom op tegen Kanker","award":["Emmanuel van der Schueren research grant"],"award-info":[{"award-number":["Emmanuel van der Schueren research grant"]}]},{"DOI":"10.13039\/501100005026","name":"Stichting Tegen Kanker","doi-asserted-by":"publisher","award":["2016\/818"],"award-info":[{"award-number":["2016\/818"]}],"id":[{"id":"10.13039\/501100005026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10689-018-0095-1","type":"journal-article","created":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T00:29:22Z","timestamp":1530318562000},"page":"569-576","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Molecular analysis of an asbestos-exposed Belgian family with a high prevalence of mesothelioma"],"prefix":"10.1007","volume":"17","author":[{"given":"Marieke","family":"Hylebos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Op de Beeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenneke","family":"van den Ende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Pauwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lammens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P.","family":"van Meerbeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Van Camp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,30]]},"reference":[{"issue":"7","key":"95_CR1","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/sj.bjc.6604879","volume":"100","author":"C Rake","year":"2009","unstructured":"Rake C, Gilham C, Hatch J, Darnton A, Hodgson J, Peto J (2009) Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer 100(7):1175\u20131183. \n                    https:\/\/doi.org\/10.1038\/sj.bjc.6604879","journal-title":"Br J Cancer"},{"issue":"2","key":"95_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.semtcvs.2009.06.007","volume":"21","author":"HI Pass","year":"2009","unstructured":"Pass HI, Carbone M (2009) Current status of screening for malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 21(2):97\u2013104. \n                    https:\/\/doi.org\/10.1053\/j.semtcvs.2009.06.007","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"10","key":"95_CR3","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, Tanji M, Gaudino G, Yang H, Carbone M (2011) Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 43(10):1022\u20131025. \n                    https:\/\/doi.org\/10.1038\/ng.912","journal-title":"Nat Genet"},{"issue":"32","key":"95_CR4","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1200\/JCO.2011.41.2965","volume":"30","author":"T Wiesner","year":"2012","unstructured":"Wiesner T, Fried I, Ulz P, Stacher E, Popper H, Murali R, Kutzner H, Lax S, Smolle-Juttner F, Geigl JB, Speicher MR (2012) Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations. J Clin Oncol 30(32):e337\u2013e340. \n                    https:\/\/doi.org\/10.1200\/JCO.2011.41.2965","journal-title":"J Clin Oncol"},{"issue":"5","key":"95_CR5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.cancergen.2013.05.018","volume":"206","author":"M Cheung","year":"2013","unstructured":"Cheung M, Talarchek J, Schindeler K, Saraiva E, Penney LS, Ludman M, Testa JR (2013) Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma. Cancer Genet 206(5):206\u2013210. \n                    https:\/\/doi.org\/10.1016\/j.cancergen.2013.05.018","journal-title":"Cancer Genet"},{"issue":"1","key":"95_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/gcc.22218","volume":"54","author":"M Betti","year":"2015","unstructured":"Betti M, Casalone E, Ferrante D, Romanelli A, Grosso F, Guarrera S, Righi L, Vatrano S, Pelosi G, Libener R, Mirabelli D, Boldorini R, Casadio C, Papotti M, Matullo G, Magnani C, Dianzani I (2015) Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area. Genes Chromosomes Cancer 54(1):51\u201362. \n                    https:\/\/doi.org\/10.1002\/gcc.22218","journal-title":"Genes Chromosomes Cancer"},{"issue":"17","key":"95_CR7","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1158\/1078-0432.CCR-11-2375","volume":"18","author":"M Ladanyi","year":"2012","unstructured":"Ladanyi M, Zauderer MG, Krug LM, Ito T, McMillan R, Bott M, Giancotti F (2012) New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment. Clin Cancer Res 18(17):4485\u20134490. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2375","journal-title":"Clin Cancer Res"},{"issue":"10","key":"95_CR8","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/ng.910","volume":"43","author":"T Wiesner","year":"2011","unstructured":"Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, Windpassinger C, Wackernagel W, Loy S, Wolf I, Viale A, Lash AE, Pirun M, Socci ND, Rutten A, Palmedo G, Abramson D, Offit K, Ott A, Becker JC, Cerroni L, Kutzner H, Bastian BC, Speicher MR (2011) Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 43(10):1018\u20131021. \n                    https:\/\/doi.org\/10.1038\/ng.910","journal-title":"Nat Genet"},{"issue":"12","key":"95_CR9","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","volume":"48","author":"MH Abdel-Rahman","year":"2011","unstructured":"Abdel-Rahman MH, Pilarski R, Cebulla CM, Massengill JB, Christopher BN, Boru G, Hovland P, Davidorf FH (2011) Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet 48(12):856\u2013859. \n                    https:\/\/doi.org\/10.1136\/jmedgenet-2011-100156","journal-title":"J Med Genet"},{"issue":"4","key":"95_CR10","doi-asserted-by":"publisher","first-page":"e35295","DOI":"10.1371\/journal.pone.0035295","volume":"7","author":"CN Njauw","year":"2012","unstructured":"Njauw CN, Kim I, Piris A, Gabree M, Taylor M, Lane AM, DeAngelis MM, Gragoudas E, Duncan LM, Tsao H (2012) Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS ONE 7(4):e35295. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0035295","journal-title":"PLoS ONE"},{"issue":"6","key":"95_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/pcmr.12006","volume":"25","author":"K Wadt","year":"2012","unstructured":"Wadt K, Choi J, Chung JY, Kiilgaard J, Heegaard S, Drzewiecki KT, Trent JM, Hewitt SM, Hayward NK, Gerdes AM, Brown KM (2012) A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma. Pigment Cell Melanoma Res 25(6):815\u2013818. \n                    https:\/\/doi.org\/10.1111\/pcmr.12006","journal-title":"Pigment Cell Melanoma Res"},{"issue":"4","key":"95_CR12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/gcc.22035","volume":"52","author":"V Hoiom","year":"2013","unstructured":"Hoiom V, Edsgard D, Helgadottir H, Eriksson H, All-Ericsson C, Tuominen R, Ivanova I, Lundeberg J, Emanuelsson O, Hansson J (2013) Hereditary uveal melanoma: a report of a germline mutation in BAP1. Genes Chromosomes Cancer 52(4):378\u2013384. \n                    https:\/\/doi.org\/10.1002\/gcc.22035","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"95_CR13","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","volume":"92","author":"T Popova","year":"2013","unstructured":"Popova T, Hebert L, Jacquemin V, Gad S, Caux-Moncoutier V, Dubois-d\u2019Enghien C, Richaudeau B, Renaudin X, Sellers J, Nicolas A, Sastre-Garau X, Desjardins L, Gyapay G, Raynal V, Sinilnikova OM, Andrieu N, Manie E, de Pauw A, Gesta P, Bonadona V, Maugard CM, Penet C, Avril MF, Barillot E, Cabaret O, Delattre O, Richard S, Caron O, Benfodda M, Hu HH, Soufir N, Bressac-de Paillerets B, Stoppa-Lyonnet D, Stern MH (2013) Germline BAP1 mutations predispose to renal cell carcinomas. Am J Hum Genet 92(6):974\u2013980. \n                    https:\/\/doi.org\/10.1016\/j.ajhg.2013.04.012","journal-title":"Am J Hum Genet"},{"issue":"2","key":"95_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/gcc.22129","volume":"53","author":"R Pilarski","year":"2014","unstructured":"Pilarski R, Cebulla CM, Massengill JB, Rai K, Rich T, Strong L, McGillivray B, Asrat MJ, Davidorf FH, Abdel-Rahman MH (2014) Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases. Genes Chromosomes Cancer 53(2):177\u2013182. \n                    https:\/\/doi.org\/10.1002\/gcc.22129","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"95_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/cge.12472","volume":"88","author":"A Fouchardiere de la","year":"2015","unstructured":"de la Fouchardiere A, Cabaret O, Savin L, Combemale P, Schvartz H, Penet C, Bonadona V, Soufir N, Bressac-de Paillerets B (2015) Germline BAP1 mutations predispose also to multiple basal cell carcinomas. Clin Genet 88(3):273\u2013277. \n                    https:\/\/doi.org\/10.1111\/cge.12472","journal-title":"Clin Genet"},{"issue":"3","key":"95_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/cge.12501","volume":"88","author":"KA Wadt","year":"2015","unstructured":"Wadt KA, Aoude LG, Johansson P, Solinas A, Pritchard A, Crainic O, Andersen MT, Kiilgaard JF, Heegaard S, Sunde L, Federspiel B, Madore J, Thompson JF, McCarthy SW, Goodwin A, Tsao H, Jonsson G, Busam K, Gupta R, Trent JM, Gerdes AM, Brown KM, Scolyer RA, Hayward NK (2015) A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma. Clin Genet 88(3):267\u2013272. \n                    https:\/\/doi.org\/10.1111\/cge.12501","journal-title":"Clin Genet"},{"issue":"2","key":"95_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.canlet.2015.09.011","volume":"369","author":"M Cheung","year":"2015","unstructured":"Cheung M, Kadariya Y, Talarchek J, Pei J, Ohar JA, Kayaleh OR, Testa JR (2015) Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interaction. Cancer Lett 369(2):261\u2013265. \n                    https:\/\/doi.org\/10.1016\/j.canlet.2015.09.011","journal-title":"Cancer Lett"},{"issue":"3","key":"95_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cancergen.2015.12.007","volume":"209","author":"KJ McDonnell","year":"2016","unstructured":"McDonnell KJ, Gallanis GT, Heller KA, Melas M, Idos GE, Culver JO, Martin SE, Peng DH, Gruber SB (2016) A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer. Cancer Genet 209(3):75\u201381. \n                    https:\/\/doi.org\/10.1016\/j.cancergen.2015.12.007","journal-title":"Cancer Genet"},{"issue":"10","key":"95_CR19","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.cancergen.2015.07.004","volume":"208","author":"M Cheung","year":"2015","unstructured":"Cheung M, Kadariya Y, Pei J, Talarchek J, Facciolo F, Visca P, Righi L, Cozzi I, Testa JR, Ascoli V (2015) An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation. Cancer Genet 208(10):502\u2013507. \n                    https:\/\/doi.org\/10.1016\/j.cancergen.2015.07.004","journal-title":"Cancer Genet"},{"issue":"9","key":"95_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cancergen.2016.07.002","volume":"209","author":"V Ascoli","year":"2016","unstructured":"Ascoli V, Cozzi I, Vatrano S, Izzo S, Giorcelli J, Romeo E, Carnovale-Scalzo C, Grillo LR, Facciolo F, Visca P, Papotti M, Righi L (2016) Mesothelioma families without inheritance of a BAP1 predisposing mutation. Cancer Genet 209(9):381\u2013387. \n                    https:\/\/doi.org\/10.1016\/j.cancergen.2016.07.002","journal-title":"Cancer Genet"},{"issue":"7","key":"95_CR21","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ng.855","volume":"43","author":"M Bott","year":"2011","unstructured":"Bott M, Brevet M, Taylor BS, Shimizu S, Ito T, Wang L, Creaney J, Lake RA, Zakowski MF, Reva B, Sander C, Delsite R, Powell S, Zhou Q, Shen R, Olshen A, Rusch V, Ladanyi M (2011) The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet 43(7):668\u2013672. \n                    https:\/\/doi.org\/10.1038\/ng.855","journal-title":"Nat Genet"},{"issue":"4","key":"95_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<649::AID-IJC25>3.0.CO;2-2","volume":"75","author":"JB Prins","year":"1998","unstructured":"Prins JB, Williamson KA, Kamp MM, Van Hezik EJ, Van der Kwast TH, Hagemeijer A, Versnel MA (1998) The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma. Int J Cancer 75(4):649\u2013653","journal-title":"Int J Cancer"},{"issue":"6","key":"95_CR23","first-page":"1227","volume":"55","author":"Y Sekido","year":"1995","unstructured":"Sekido Y, Pass HI, Bader S, Mew DJ, Christman MF, Gazdar AF, Minna JD (1995) Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res 55(6):1227\u20131231","journal-title":"Cancer Res"},{"issue":"10","key":"95_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13073-014-0074-6","volume":"6","author":"G Vandeweyer","year":"2014","unstructured":"Vandeweyer G, Van Laer L, Loeys B, Van den Bulcke T, Kooy RF (2014) VariantDB: a flexible annotation and filtering portal for next generation sequencing data. Genome Med 6(10):74. \n                    https:\/\/doi.org\/10.1186\/s13073-014-0074-6","journal-title":"Genome Med"},{"issue":"3","key":"95_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrc1299","volume":"4","author":"PA Futreal","year":"2004","unstructured":"Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR (2004) A census of human cancer genes. Nat Rev Cancer 4(3):177\u2013183. \n                    https:\/\/doi.org\/10.1038\/nrc1299","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"95_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz JM, Cooper DN, Schuelke M, Seelow D (2014) MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11(4):361\u2013362. \n                    https:\/\/doi.org\/10.1038\/nmeth.2890","journal-title":"Nat Methods"},{"issue":"4","key":"95_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248\u2013249. \n                    https:\/\/doi.org\/10.1038\/nmeth0410-248","journal-title":"Nat Methods"},{"issue":"Web Server issu","key":"95_CR28","doi-asserted-by":"publisher","first-page":"W452457","DOI":"10.1093\/nar\/gks539","volume":"40","author":"NL Sim","year":"2012","unstructured":"Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC (2012) SIFT web server: predicting effects of amino acid substitutions on proteins. Nucl Acids Res 40 (Web Server issue):W452\u2013W457. \n                    https:\/\/doi.org\/10.1093\/nar\/gks539","journal-title":"Nucl Acids Res"},{"key":"95_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1098","author":"DR Zerbino","year":"2017","unstructured":"Zerbino DR, Achuthan P, Akanni W, Amode MR, Barrell D, Bhai J, Billis K, Cummins C, Gall A, Giron CG, Gil L, Gordon L, Haggerty L, Haskell E, Hourlier T, Izuogu OG, Janacek SH, Juettemann T, To JK, Laird MR, Lavidas I, Liu Z, Loveland JE, Maurel T, McLaren W, Moore B, Mudge J, Murphy DN, Newman V, Nuhn M, Ogeh D, Ong CK, Parker A, Patricio M, Riat HS, Schuilenburg H, Sheppard D, Sparrow H, Taylor K, Thormann A, Vullo A, Walts B, Zadissa A, Frankish A, Hunt SE, Kostadima M, Langridge N, Martin FJ, Muffato M, Perry E, Ruffier M, Staines DM, Trevanion SJ, Aken BL, Cunningham F, Yates A, Flicek P (2017) Ensembl 2018. Nucl Acids Res. \n                    https:\/\/doi.org\/10.1093\/nar\/gkx1098","journal-title":"Nucl Acids Res"},{"key":"95_CR30","unstructured":"Multiplicom. \n                    http:\/\/www.agilent.com"},{"issue":"69","key":"95_CR31","doi-asserted-by":"publisher","first-page":"113673","DOI":"10.18632\/oncotarget.22817","volume":"8","author":"M Hylebos","year":"2017","unstructured":"Hylebos M, Van Camp G, Vandeweyer G, Fransen E, Beyens M, Cornelissen R, Suls A, Pauwels P, van Meerbeeck JP, Op de Beeck K (2017) Large-scale copy number analysis reveals variations in genes not previously associated with malignant pleural mesothelioma. Oncotarget 8(69):113673\u2013113686. \n                    https:\/\/doi.org\/10.18632\/oncotarget.22817","journal-title":"Oncotarget"},{"key":"95_CR32","unstructured":"Exome Variant Server NHLBI GO Exome Sequencing Project (ESP). \n                    http:\/\/evs.gs.washington.edu\/EVS\/\n                    \n                  . Accessed Jan 2018"},{"issue":"7616","key":"95_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O\u2019Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP, Kosmicki JA, Duncan LE, Estrada K, Zhao F, Zou J, Pierce-Hoffman E, Berghout J, Cooper DN, Deflaux N, DePristo M, Do R, Flannick J, Fromer M, Gauthier L, Goldstein J, Gupta N, Howrigan D, Kiezun A, Kurki MI, Moonshine AL, Natarajan P, Orozco L, Peloso GM, Poplin R, Rivas MA, Ruano-Rubio V, Rose SA, Ruderfer DM, Shakir K, Stenson PD, Stevens C, Thomas BP, Tiao G, Tusie-Luna MT, Weisburd B, Won HH, Yu D, Altshuler DM, Ardissino D, Boehnke M, Danesh J, Donnelly S, Elosua R, Florez JC, Gabriel SB, Getz G, Glatt SJ, Hultman CM, Kathiresan S, Laakso M, McCarroll S, McCarthy MI, McGovern D, McPherson R, Neale BM, Palotie A, Purcell SM, Saleheen D, Scharf JM, Sklar P, Sullivan PF, Tuomilehto J, Tsuang MT, Watkins HC, Wilson JG, Daly MJ, MacArthur DG, Exome Aggregation C (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536(7616):285\u2013291. \n                    https:\/\/doi.org\/10.1038\/nature19057","journal-title":"Nature"},{"key":"95_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.canlet.2017.06.028","volume":"405","author":"M Betti","year":"2017","unstructured":"Betti M, Casalone E, Ferrante D, Aspesi A, Morleo G, Biasi A, Sculco M, Mancuso G, Guarrera S, Righi L, Grosso F, Libener R, Pavesi M, Mariani N, Casadio C, Boldorini R, Mirabelli D, Pasini B, Magnani C, Matullo G, Dianzani I (2017) Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma. Cancer Lett 405:38\u201345. \n                    https:\/\/doi.org\/10.1016\/j.canlet.2017.06.028","journal-title":"Cancer Lett"},{"key":"#cr-split#-95_CR35.1","unstructured":"Hassan R, Morrow B, Walsh T, Lee MK, Gao J, Mian I, Khan J, Raffeld M, Patel S, Xi L, Wei JS, Schrump D, Hesdorffer M, Zhang J, Calzone K, Padiernos E, Alewine C, Steinberg SM, Thomas A, King M-C (2018) Inherited predisposition to malignant mesothelioma"},{"key":"#cr-split#-95_CR35.2","unstructured":"(MM) due to mutations in DNA repair genes. [Abstract] ASCO June 1-5 2018, Chicago, USA"},{"key":"95_CR36","doi-asserted-by":"crossref","unstructured":"Panou V, Gadiraju M, Wolin A, Weipert CM, Skarda E, Husain AN, Patel JD, Rose B, Nelakuditi V, Knight Johnson A, Helgeson M, Fischer D, Sulai N, Turaga K, Huo D, Segal J, Kadri S, Li Z, Kindler HL, Churpek JE (2018) Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma. [Abstract] ASCO June 1\u20135 2018, Chicago, USA","DOI":"10.1200\/JCO.2018.36.15_suppl.8564"},{"issue":"4","key":"95_CR37","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","volume":"10","author":"M Nasu","year":"2015","unstructured":"Nasu M, Emi M, Pastorino S, Tanji M, Powers A, Luk H, Baumann F, Zhang YA, Gazdar A, Kanodia S, Tiirikainen M, Flores E, Gaudino G, Becich MJ, Pass HI, Yang H, Carbone M (2015) High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma. J Thorac Oncol 10(4):565\u2013576. \n                    https:\/\/doi.org\/10.1097\/JTO.0000000000000471","journal-title":"J Thorac Oncol"},{"issue":"44","key":"95_CR38","doi-asserted-by":"publisher","first-page":"36935","DOI":"10.1074\/jbc.M501725200","volume":"280","author":"E Hiriart","year":"2005","unstructured":"Hiriart E, Gruffat H, Buisson M, Mikaelian I, Keppler S, Meresse P, Mercher T, Bernard OA, Sergeant A, Manet E (2005) Interaction of the Epstein-Barr virus mRNA export factor EB2 with human Spen proteins SHARP, OTT1, and a novel member of the family, OTT3, links Spen proteins with splicing regulation and mRNA export. J Biol Chem 280(44):36935\u201336945. \n                    https:\/\/doi.org\/10.1074\/jbc.M501725200","journal-title":"J Biol Chem"},{"issue":"2","key":"95_CR39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1128\/MCB.00370-08","volume":"29","author":"GD Raffel","year":"2009","unstructured":"Raffel GD, Chu GC, Jesneck JL, Cullen DE, Bronson RT, Bernard OA, Gilliland DG (2009) Ott1 (Rbm15) is essential for placental vascular branching morphogenesis and embryonic development of the heart and spleen. Mol Cell Biol 29(2):333\u2013341. \n                    https:\/\/doi.org\/10.1128\/MCB.00370-08","journal-title":"Mol Cell Biol"},{"issue":"3","key":"95_CR40","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/90054","volume":"28","author":"Z Ma","year":"2001","unstructured":"Ma Z, Morris SW, Valentine V, Li M, Herbrick JA, Cui X, Bouman D, Li Y, Mehta PK, Nizetic D, Kaneko Y, Chan GC, Chan LC, Squire J, Scherer SW, Hitzler JK (2001) Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nat Genet 28(3):220\u2013221. \n                    https:\/\/doi.org\/10.1038\/90054","journal-title":"Nat Genet"},{"issue":"10","key":"95_CR41","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1073\/pnas.101001498","volume":"98","author":"T Mercher","year":"2001","unstructured":"Mercher T, Coniat MB, Monni R, Mauchauffe M, Nguyen Khac F, Gressin L, Mugneret F, Leblanc T, Dastugue N, Berger R, Bernard OA (2001) Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia. Proc Natl Acad Sci USA 98(10):5776\u20135779. \n                    https:\/\/doi.org\/10.1073\/pnas.101001498","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-018-0095-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-018-0095-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-018-0095-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T15:46:22Z","timestamp":1569253582000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-018-0095-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,30]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["95"],"URL":"https:\/\/doi.org\/10.1007\/s10689-018-0095-1","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,30]]},"assertion":[{"value":"30 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}